Publication:
Is parenteral levothyroxine therapy safe in intractable hypothyroidism?

dc.contributor.authorPeynirci, Hande
dc.contributor.authorTaşkıran, Bengür
dc.contributor.buuauthorErtürk, Erdinç
dc.contributor.buuauthorŞişman, Pınar
dc.contributor.buuauthorErsoy, Canan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentEndokrinoloji ve Metabolik Bozukluklar Ana Bilim Dalı
dc.contributor.researcheridAAJ-6536-2021
dc.contributor.researcheridAAH-8861-2021
dc.contributor.scopusid7005488796
dc.contributor.scopusid57190169474
dc.contributor.scopusid6701485882
dc.date.accessioned2023-10-04T08:12:54Z
dc.date.available2023-10-04T08:12:54Z
dc.date.issued2018-06
dc.description.abstractCase: A 32-year old woman was admitted to the hospital due to intractable hypothyroidism refractory to high dose of oral L-thyroxine therapy. She underwent total thyroidectomy and radioactive iodine therapy due to papillary thyroid cancer. After excluding poor adherence to therapy and malabsorption, levothyroxine absorption test was performed. No response was detected. Transient neurologic symptoms developed during the test. She developed 3 attacks consisting of neurologic symptoms during high dose administration. The patient was considered a case of isolated L-thyroxine malabsorption. She became euthyroid after intramuscular twice weekly L-thyroxine therapy. Discussion: There are a few case reports regarding isolated L-thyroxine. We report successful long term results of twice weekly administered intramuscular L-thyroxine therapy. We also draw attention to neurologic side effects of high dose L-thyroxine therapy.
dc.identifier.citationPeynirci, H. vd. (2018). ''Is parenteral levothyroxine therapy safe in intractable hypothyroidism?''. Journal of the National Medical Association, 110(3), 245-249.
dc.identifier.endpage249
dc.identifier.issn0027-9684
dc.identifier.issn1943-4693
dc.identifier.issue3
dc.identifier.pubmed29778126
dc.identifier.scopus2-s2.0-85020916109
dc.identifier.startpage245
dc.identifier.urihttps://doi.org/10.1016/j.jnma.2017.05.007
dc.identifier.urihttps://www.sciencedirect.com/science/article/abs/pii/S0027968417300287
dc.identifier.urihttp://hdl.handle.net/11452/34195
dc.identifier.volume110
dc.identifier.wos000432909100008
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherNatl Med Assoc
dc.relation.collaborationSanayi
dc.relation.journalJournal of the National Medical Association
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGeneral & internal medicine
dc.subjectHypothyroidism
dc.subjectLevothyroxine
dc.subjectMalabsorption
dc.subjectNeurologic manifestations
dc.subjectThyroxine absorption
dc.subjectPseudomalabsorption
dc.subjectMalabsorption
dc.subjectReplacement
dc.subjectPatient
dc.subjectDisease
dc.subject.emtreeAcetylsalicylic acid
dc.subject.emtreeLevothyroxine
dc.subject.emtreeLiothyronine
dc.subject.emtreeThyrotropin
dc.subject.emtreeThyroxine
dc.subject.emtreeAdult
dc.subject.emtreeAphasia
dc.subject.emtreeArticle
dc.subject.emtreeBlood pressure
dc.subject.emtreeBody mass
dc.subject.emtreeBody temperature
dc.subject.emtreeBody weight gain
dc.subject.emtreeCase report
dc.subject.emtreeClinical article
dc.subject.emtreeDrug megadose
dc.subject.emtreeDrug safety
dc.subject.emtreeDry skin
dc.subject.emtreeFatigue
dc.subject.emtreeFemale
dc.subject.emtreeFree thyroxine index
dc.subject.emtreeHeart rate
dc.subject.emtreeHemiparesis
dc.subject.emtreeHuman
dc.subject.emtreeHypertension
dc.subject.emtreeHypothyroidism
dc.subject.emtreeMenstruation
dc.subject.emtreePhysical examination
dc.subject.emtreePriority journal
dc.subject.emtreeSide effect
dc.subject.emtreeThyroid function test
dc.subject.emtreeThyrotropin blood level
dc.subject.emtreeTransient ischemic attack
dc.subject.emtreeTreatment response
dc.subject.emtreeVisual impairment
dc.subject.emtreeHypothyroidism
dc.subject.emtreeIntestine absorption
dc.subject.emtreeIntramuscular drug administration
dc.subject.emtreeMalabsorption
dc.subject.emtreeMetabolism
dc.subject.emtreeOral drug administration
dc.subject.emtreePathology
dc.subject.emtreePathophysiology
dc.subject.emtreeProcedures
dc.subject.emtreeThyroid tumor
dc.subject.emtreeThyroidectomy
dc.subject.emtreeTreatment outcome
dc.subject.meshAdministration, oral
dc.subject.meshAdult
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshHypothyroidism
dc.subject.meshInjections, intramuscular
dc.subject.meshIntestinal absorption
dc.subject.meshMalabsorption syndromes
dc.subject.meshThyroid cancer, papillary
dc.subject.meshThyroid neoplasms
dc.subject.meshThyroidectomy
dc.subject.meshThyroxine
dc.subject.meshTreatment outcome
dc.subject.scopusLevothyroxine Sodium; Hypothyroidism; Thyrotropin
dc.subject.wosMedicine, general & internal
dc.titleIs parenteral levothyroxine therapy safe in intractable hypothyroidism?
dc.typeArticle
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Endokrinoloji ve Metabolik Bozukluklar Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: